Barclays Boosts McKesson (MCK) Price Target, Says Shares Likely to Stay in Favor

On February 18, Barclays raised its terms nonsubjective connected McKesson Corporation (NYSE:MCK) to $1,050 from $960. The steadfast reiterated an Overweight standing connected the shares. Analysts said the banal is expected to “remain successful favor” arsenic investors look for “pockets of information wrong healthcare.” At the aforesaid time, the steadfast noted that McKesson present trades astatine a 15% premium to its three-year average.

On January 30, McKesson confirmed it had completed the merchantability of its retail and organisation businesses successful Norway. The purchaser was NorgesGruppen, a privately owned retail group. This woody marked an important measurement successful the company’s ongoing restructuring. McKesson had archetypal announced plans connected August 4, 2025, to divest its Norway business, which was portion of the Other segment. This determination represented the last measurement successful its effort to afloat exit European operations.

The institution said the determination allows it to sharpen its focus. Management plans to nonstop strategy and superior toward maturation areas, particularly Oncology, Multispecialty, and Biopharma Services. These segments present signifier the halfway of McKesson’s semipermanent priorities.

McKesson Corporation (NYSE:MCK) operates arsenic a diversified healthcare services company. Its enactment centers connected improving wellness outcomes and supporting diligent attraction crossed its network.

While we admit the imaginable of MCK arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 13 Best Strong Buy Dividend Stocks to Invest In and 14 Best Low Volatility Dividend Stocks to Invest In

Disclosure: None. Follow Insider Monkey connected Google News.